Authors: Miller, MD Margot, NA Lamy, PD Fuller, MD Anton, KE Mulato, AS Cherrington, JM

Citation: Md. Miller et al., Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408, J ACQ IMM D, 27(5), 2001, pp. 450-458

Authors: Wainberg, MA Miller, MD Quan, YD Salomon, H Mulato, AS Lamy, PD Margot, NA Anton, KE Cherrington, JM

Citation: Ma. Wainberg et al., In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA, ANTIVIR TH, 4(2), 1999, pp. 87-94

Authors: Miller, MD Anton, KE Mulato, AS Lamy, PD Cherrington, JM

Citation: Md. Miller et al., Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro, J INFEC DIS, 179(1), 1999, pp. 92-100